Aprea Therapeutics APRE
NASDAQ APRE
$0.72 -0.03 (-4.00%)
As of: Oct 1, 2026 · 3:59 PM EDT

Aprea Therapeutics (APRE) Other Non-Current Assets (2018 - 2026)

Updated

Aprea Therapeutics (APRE) posted Other Non-Current Assets of $271,162 for Q2 2026, unchanged from $271,162 a year earlier and unchanged from the prior quarter.

Analysis

Aprea Therapeutics (APRE) Other Non-Current Assets (2018 - 2026) Analysis & Trends

Since Q4 2018, Aprea Therapeutics has reported Other Non-Current Assets for 27 quarters.

  • Annual Other Non-Current Assets shows a five-year compound annual growth rate of 56.0% (FY2020 to FY2025).
  • In prior years, Aprea Therapeutics' Other Non-Current Assets was $281,662 in FY2024 (+591.8%), $40,717 in FY2023 and $29,372 in FY2021 (unchanged).
  • Quarterly Other Non-Current Assets has run from a low of $29,351 in Q3 2022 to a high of $281,662 in Q4 2024 over five years.
  • On a year-over-year basis, Other Non-Current Assets increased in three of the last eight quarters, with growth averaging 217.8%.
  • The strongest year-over-year quarter for Other Non-Current Assets in the past five years was Q3 2024, with growth of 596.3%; the weakest was Q3 2025, with a decline of 3.7%.
  • According to Business Quant data, Other Non-Current Assets for the three prior quarters was $271,162 (Q1 2026), $271,162 (Q4 2025) and $271,162 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 14.27 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 10.73 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 19.60 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 5.93 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 12.98 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 4.75 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 9.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 1.25 Bn
10 Aprea Therapeutics 40.11 Mn 40.11 Mn - 271,162.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 271,162.00
Mar 31, 2026 271,162.00
Dec 31, 2025 271,162.00
Sep 30, 2025 271,162.00
Jun 30, 2025 271,162.00
Mar 31, 2025 271,162.00
Dec 31, 2024 281,662.00
Sep 30, 2024 281,662.00
Jun 30, 2024 271,162.00
Mar 31, 2024 40,986.00
Dec 31, 2023 40,717.00
Sep 30, 2023 40,449.00
Jun 30, 2023 40,180.00
Sep 30, 2022 29,351.00
Jun 30, 2022 29,359.00
Mar 31, 2022 29,369.00
Dec 31, 2021 29,372.00
Sep 30, 2021 29,375.00
Jun 30, 2021 29,379.00
Mar 31, 2021 29,376.00
API Access

Aprea Therapeutics Other Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=APRE&period=max&api_key=YOUR_API_KEY